Please provide your email address to receive an email when new articles are posted on . DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by ...

Scientists discovered that rearranging a peptide’s placement in a spherical nucleic acid vaccine dramatically improves immune response against HPV-driven tumors. The findings have the potential to ...

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

February 14, 2008 — Patients with head and neck cancer positive for human papillomavirus (HPV) have a better response to chemotherapy and chemoradiation and better overall survival than patients with ...

PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotechnology company focusing on innovative protein-based vaccines, and Gustave Roussy, the leading cancer centre in Europe ranked third Best ...

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to Cleveland Clinic research. The study, published in the Journal of ...

A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma. Economic ...

Detection of antibodies to the HPV16 proteome in head and neck cancer patient sera. Background: HPV infection has been known to be one of the important risk factors for carcinogenesis of head and neck ...

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which "reset the bar" for future trials of ...

The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell ...